# MDARIX R1 — Day 22 Website & Authentication Validation Report

## Objective

Create one coherent public MDARIX website, identity/authentication experience, and protected application entry.

## Website and design

Added responsive public routes for the homepage, Platform, Solutions, AI Trust, Integrations, Security, and Request Demo. The copy positions MDARIX as medical-device lifecycle investigation and decision intelligence: a System of Intelligence, not System of Record. No competitor assets, customer logos, testimonials, certifications, or unsupported regulatory claims were added.

Added shared design tokens/components for public hero, story cards, navigation, CTA, forms, auth cards, focus states, responsive mobile layout, and status messaging.

## Authentication

Added signup, verification, sign-in, sign-out, forgot-password, reset-password, session, and server-derived context endpoints. Passwords use salted scrypt hashes; verification/reset tokens are random, hashed, single-use, and time-limited. Signup creates a pending sandbox tenant and grants no production administrator privilege.

## Application handoff

Authentication context resolves tenant, user, active role, and effective permissions for the protected application. Day21 authorization remains server-side. The UI displays the server-derived user name and active role. Future OIDC/SAML and Day23 password re-authentication have documented abstraction boundaries.

## Validation

- Auth targeted tests: `2 passed, 0 failed, 0 errors`.
- Full regression: `223 passed, 0 failed, 0 errors, 3 understood warnings`.
- Frontend build: PASS.
- Plaintext passwords: 0.
- Password hash/token exposure: 0 in normal API responses.
- Authentication bypass: 0 in tested local-auth paths.
- Cross-tenant auth leakage: 0 in controlled context model.
- Competitor asset/copy reuse: 0.

## Known limitations

Production email provider, SSO/OIDC/SAML, MFA, CAPTCHA/bot protection, persistent production user administration, full route middleware, legal Privacy/Terms copy, and external penetration testing remain future work.

## Final status

`DAY 22 STATUS: PASS`
